Kimberly S. Collins

647 total citations
19 papers, 340 citations indexed

About

Kimberly S. Collins is a scholar working on Molecular Biology, Pharmacology and Nephrology. According to data from OpenAlex, Kimberly S. Collins has authored 19 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Pharmacology and 4 papers in Nephrology. Recurrent topics in Kimberly S. Collins's work include Pharmacogenetics and Drug Metabolism (5 papers), Renal and related cancers (3 papers) and Chronic Kidney Disease and Diabetes (3 papers). Kimberly S. Collins is often cited by papers focused on Pharmacogenetics and Drug Metabolism (5 papers), Renal and related cancers (3 papers) and Chronic Kidney Disease and Diabetes (3 papers). Kimberly S. Collins collaborates with scholars based in United States, India and Brazil. Kimberly S. Collins's co-authors include Michael T. Eadon, Ying‐Hua Cheng, Pierre C. Dagher, Takashi Hato, Tarek M. El‐Achkar, Ricardo Melo Ferreira, Seth Winfree, Danielle Janosevic, Xiaoling Xuei and Daria Barwinska and has published in prestigious journals such as Science Advances, eLife and Nephrology Dialysis Transplantation.

In The Last Decade

Kimberly S. Collins

18 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kimberly S. Collins United States 9 194 92 61 32 31 19 340
Wenyuan Zheng China 8 171 0.9× 108 1.2× 59 1.0× 21 0.7× 95 3.1× 16 356
Xiuqing Dong China 10 113 0.6× 73 0.8× 23 0.4× 34 1.1× 25 0.8× 11 305
Jörg‐Martin Bangen Germany 5 205 1.1× 48 0.5× 40 0.7× 53 1.7× 47 1.5× 6 365
Chengguo Wei United States 11 74 0.4× 61 0.7× 28 0.5× 39 1.2× 18 0.6× 18 263
Yinshuang Li China 6 277 1.4× 117 1.3× 130 2.1× 46 1.4× 23 0.7× 9 374
Young-Suk Lee South Korea 11 207 1.1× 111 1.2× 46 0.8× 49 1.5× 28 0.9× 14 649
A. Fleishman United States 8 168 0.9× 23 0.3× 54 0.9× 43 1.3× 24 0.8× 15 528
Longli Kang China 12 141 0.7× 22 0.2× 26 0.4× 18 0.6× 61 2.0× 36 347
Haoqiang Hu China 5 219 1.1× 105 1.1× 118 1.9× 23 0.7× 13 0.4× 8 335
Kasey R. Cargill United States 9 182 0.9× 46 0.5× 59 1.0× 22 0.7× 52 1.7× 13 356

Countries citing papers authored by Kimberly S. Collins

Since Specialization
Citations

This map shows the geographic impact of Kimberly S. Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberly S. Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberly S. Collins more than expected).

Fields of papers citing papers by Kimberly S. Collins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimberly S. Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberly S. Collins. The network helps show where Kimberly S. Collins may publish in the future.

Co-authorship network of co-authors of Kimberly S. Collins

This figure shows the co-authorship network connecting the top 25 collaborators of Kimberly S. Collins. A scholar is included among the top collaborators of Kimberly S. Collins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimberly S. Collins. Kimberly S. Collins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Collins, Kimberly S., Blessed Winston Aruldhas, Ingrid F. Metzger, et al.. (2025). A Population Pharmacokinetic Approach to Understand the Effect of Efavirenz on CYP3A Activity in Healthy Volunteers Using Midazolam as a Probe. CPT Pharmacometrics & Systems Pharmacology. 14(12). 2095–2106.
2.
Collins, Kimberly S., Michael T. Eadon, Ying‐Hua Cheng, et al.. (2022). Alterations in Protein Translation and Carboxylic Acid Catabolic Processes in Diabetic Kidney Disease. Cells. 11(7). 1166–1166. 8 indexed citations
3.
Janosevic, Danielle, Jered Myslinski, Thomas McCarthy, et al.. (2021). The orchestrated cellular and molecular responses of the kidney to endotoxin define a precise sepsis timeline. eLife. 10. 93 indexed citations
4.
Barwinska, Daria, Tarek M. El‐Achkar, Ricardo Melo Ferreira, et al.. (2021). Molecular characterization of the human kidney interstitium in health and disease. Science Advances. 7(7). 28 indexed citations
5.
Ferreira, Ricardo Melo, Angela R. Sabo, Seth Winfree, et al.. (2021). Integration of spatial and single-cell transcriptomics localizes epithelial cell–immune cross-talk in kidney injury. JCI Insight. 6(12). 109 indexed citations
6.
Eadon, Michael T., Kimberly S. Collins, Ricardo Melo Ferreira, et al.. (2020). Clinical, histopathologic and molecular features of idiopathic and diabetic nodular mesangial sclerosis in humans. Nephrology Dialysis Transplantation. 37(1). 72–84. 4 indexed citations
7.
Collins, Kimberly S., Arjun Sinha, Asif Sharfuddin, et al.. (2020). Implementation of a Renal Precision Medicine Program: Clinician Attitudes and Acceptance. PMC. 1 indexed citations
8.
Collins, Kimberly S., et al.. (2020). Genotype-Guided Hydralazine Therapy. American Journal of Nephrology. 51(10). 764–776. 21 indexed citations
9.
Ferreira, Christina R., Kimberly S. Collins, Michael T. Eadon, et al.. (2020). Multiple reaction monitoring profiling as an analytical strategy to investigate lipids in extracellular vesicles. Journal of Mass Spectrometry. 56(1). e4681–e4681. 6 indexed citations
10.
Collins, Kimberly S., Ying‐Hua Cheng, Ricardo Melo Ferreira, et al.. (2020). Interindividual Variability in Lymphocyte Stimulation and Transcriptomic Response Predicts Mycophenolic Acid Sensitivity in Healthy Volunteers. Clinical and Translational Science. 13(6). 1137–1149. 2 indexed citations
11.
Collins, Kimberly S., Arjun Sinha, Asif Sharfuddin, et al.. (2020). Implementation of a Renal Precision Medicine Program: Clinician Attitudes and Acceptance. Life. 10(4). 32–32. 11 indexed citations
12.
Collins, Kimberly S., Ingrid F. Metzger, Brandon T. Gufford, et al.. (2019). Influence of Uridine Diphosphate Glucuronosyltransferase Family 1 Member A1 and Solute Carrier Organic Anion Transporter Family 1 Member B1 Polymorphisms and Efavirenz on Bilirubin Disposition in Healthy Volunteers. Drug Metabolism and Disposition. 48(3). 169–175. 5 indexed citations
13.
Collins, Kimberly S., et al.. (2018). Improving the Patency of Jugular Vein Catheters in Sprague–Dawley Rats by Using an Antiseptic Nitrocellulose Coating. Journal of the American Association for Laboratory Animal Science. 57(5). 520–528. 6 indexed citations
14.
Collins, Kimberly S., Victoria M. Pratt, Marelize Swart, et al.. (2018). Analytical validity of a genotyping assay for use with personalized antihypertensive and chronic kidney disease therapy. Pharmacogenetics and Genomics. 29(1). 18–22. 9 indexed citations
15.
Swart, Marelize, et al.. (2018). Pharmacogenetics and Practice: Tailoring Prescribing for Safety and Effectiveness. The Journal for Nurse Practitioners. 14(10). 697–704.e1. 7 indexed citations
16.
Ipe, Joseph, Kimberly S. Collins, Yangyang Hao, et al.. (2018). PASSPORT-seq: A Novel High-Throughput Bioassay to Functionally Test Polymorphisms in Micro-RNA Target Sites. Frontiers in Genetics. 9. 219–219. 9 indexed citations
17.
Eadon, Michael T., Ying‐Hua Cheng, Takashi Hato, et al.. (2017). In Vivo siRNA Delivery and Rebound of Renal LRP2 in Mice. PMC. 1 indexed citations
18.
Eadon, Michael T., Ying‐Hua Cheng, Takashi Hato, et al.. (2017). In Vivo siRNA Delivery and Rebound of Renal LRP2 in Mice. Journal of Drug Delivery. 2017. 1–12. 8 indexed citations
19.
Collins, Kimberly S., et al.. (2005). The Practicality of Super Bowl Advertising for New Products and Companies. Journal of Promotion Management. 11(4). 19–31. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026